1. Home
  2. Labeler Index
  3. Sandoz Inc.
  4. 0781-3505
  5. Product Images: Enoxaparin Sodium Injection, Usp

Product Images Enoxaparin Sodium Injection, Usp

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. NDC 0781-3505-01 - 100mg blister label
  2. NDC 0781-3505-63 - 100mg carton label
  3. NDC 0781-3510-1 - 120mg blister label
  4. NDC 0781-351063 - 120mg carton label
  5. NDC 0781-3513-01 - 150mg blister label
  6. NDC 0781-3513-63 - 150mg carton label
  7. NDC 0781-3460-01 - 30mg blister label
  8. NDC 078103460-63 - 30mg carton
  9. NDC 0781-3482-01 - 40mg blister label
  10. NDC 0781-3482-63 - 40mg carton label
  11. NDC 0781-3488-01 - 60mg blister label
  12. NDC 0781-3488-63 - 60mg carton label
  13. NDC 0781-3502-01 - 80mg blister label
  14. NDC 0781-3502-63 - 80mg carton label
  15. structural formula - Chm 1
  16. chm 2 - Chm 2
  17. Figure 1 - Figure 1
  18. Figure 2 - Figure 2
  19. Figure A - Figure A
  20. Figure B - Figure B
  21. Figure C - Figure C
  22. Figure D - Figure D
  23. Figure E - Figure E
  24. Figure A - IFU Fig A
  25. Figure B - IFU Fig B
  26. Figure C - IFU Fig C
  27. Figure D - IFU Fig D
  28. Figure E - IFU Fig E
  29. Figure F - IFU Fig F
  30. Figure G - IFU Fig G
  31. Figure H - IFU Fig H
  32. Figure I - IFU Fig I
  33. Figure J - IFU Fig J
  34. Figure K - IFU Fig K
  35. Figure L - IFU Fig L
  36. Figure M - IFU Fig M
  37. Figure N - IFU Fig N
  38. parts - Parts

Product Label Images

The following 38 images provide visual information about the product associated with Enoxaparin Sodium Injection, Usp NDC 0781-3505 by Sandoz Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

NDC 0781-3505-01 - 100mg blister label

NDC 0781-3505-01 - 100mg blister label

NDC 0781-3505-63 - 100mg carton label

NDC 0781-3505-63 - 100mg carton label

This is a description of Enoxaparin Sodium injection, USP, supplied in single-dose syringes with an automatic safety device. Each syringe contains 100 mg of Enoxaparin Sodium Injection, USP derived from porcine intestinal mucosa in Water for Injection. It is meant for subcutaneous use and must be stored at 25 °C with excursions permitted to 15°C to 30°C. Dosage and administration instructions should be followed as per prescribing information. The product is distributed by Sandoz Inc., Princeton, NJ, and is a prescription-only medication.*

NDC 0781-3510-1 - 120mg blister label

NDC 0781-3510-1 - 120mg blister label

NDC 0781-351063 - 120mg carton label

NDC 0781-351063 - 120mg carton label

This text provides information on enoxaparin sodium injection in single-dose syringes with an automatic safety device. Each syringe contains 120 mg of enoxaparin derived from porcine intestinal mucosa. The dosage and administration instructions are included. It is important to keep the product out of reach of children and store it at 25°C (77°F). The product is distributed by Sandoz Inc. and has a shelf life until 05/2024.*

NDC 0781-3513-01 - 150mg blister label

NDC 0781-3513-01 - 150mg blister label

This text contains information about Enoxaparin Sodium Injection, USP, which is a medication used for preventing blood clots. It includes details about dosage, administration, storage instructions, and warnings. The medication comes in single-dose syringes with an automatic safety device. The text emphasizes storing the medication in its original carton or packaging until ready to use. It also provides information on the distributor, Sandoz Inc. from Princeton, NJ.*

NDC 0781-3513-63 - 150mg carton label

NDC 0781-3513-63 - 150mg carton label

This is a description for Enoxaparin Sodium Injection, USP provided in ten 1 mL single-dose syringes with an automatic safety device. Each syringe contains 150 mg of enoxaparin sodium derived from porcine intestinal mucosa. The dosage and administration details can be found in the prescribing information and instructions for use. It is advised to store the product at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). The product is distributed by Sandoz Inc., Princeton, NJ, and has an expiration date of May 2024.*

NDC 0781-3460-01 - 30mg blister label

NDC 0781-3460-01 - 30mg blister label

NDC 078103460-63 - 30mg carton

NDC 078103460-63 - 30mg carton

This is a description of Enoxaparin Sodium Injection, a medication used for subcutaneous administration. Each syringe contains 30 mg of Enoxaparin sodium derived from porcine intestinal mucosa. It comes in a package of ten 0.3 mL single-dose syringes with an automatic safety device. It is recommended to store this product at room temperature. Additional information on dosage and administration can be found in the prescribing information. Keep out of reach of children. This medication is distributed by Sandoz Inc.*

NDC 0781-3482-01 - 40mg blister label

NDC 0781-3482-01 - 40mg blister label

NDC 0781-3482-63 - 40mg carton label

NDC 0781-3482-63 - 40mg carton label

This text provides details about Enoxaparin Sodium Injection, USP in a dosage of 40 mg/0.4 mL. It comes in ten 0.4 mL single-dose syringes with an automatic safety device for subcutaneous use only. The medication is derived from porcine intestinal mucosa and should be stored at controlled room temperature. Dosage and administration information should be followed as per the prescribing information. Additionally, it includes a warning to keep out of reach of children. This product is distributed by Sandoz Inc. and has an expiration date of 05/2024.*

NDC 0781-3488-01 - 60mg blister label

NDC 0781-3488-01 - 60mg blister label

The text appears to be a pharmaceutical product description for Enoxaparin Sodium Injection, USP. It provides information regarding the dosage, administration, warnings, and storage instructions for the medication. The product is intended for subcutaneous use and comes in single-dose syringes with an automatic safety device. The text also mentions the dosage amount, derived from porcine intestinal mucosa, and emphasizes storing the product at the recommended temperature. The product is distributed by Sandoz Inc. in Princeton, NJ.*

NDC 0781-3488-63 - 60mg carton label

NDC 0781-3488-63 - 60mg carton label

This text provides information about a medication called Enoxaparin Sodium. It is an injection used for subcutaneous administration delivered in single-dose syringes with an automatic safety device. Each syringe contains 60 mg of enoxaparin sodium derived from porcine intestinal mucosa. It is important to keep this medication out of reach of children and store it at room temperature. Detailed dosage and administration instructions can be found in the prescribing information. The product is distributed by Sandoz Inc. and it is advised to store it in the original packaging until ready to use.*

NDC 0781-3502-01 - 80mg blister label

NDC 0781-3502-01 - 80mg blister label

NDC 0781-3502-63 - 80mg carton label

NDC 0781-3502-63 - 80mg carton label

This is a description of Enoxaparin Sodium Injection, USP with a strength of 80 mg/0.8 mL, available in ten 0.8 mL single-dose syringes with an automatic safety device. It is intended for subcutaneous use and is only available with a prescription. Each syringe contains enoxaparin sodium injection derived from porcine intestinal mucosa. The dosage and administration details can be found in the prescribing information and instructions for use. It is advised to keep this medication away from children, store at 25 °C (77°F), and store in the original packaging until ready to use. This product is distributed by Sandoz Inc., Princeton, NJ 08540.*

structural formula - Chm 1

structural formula - Chm 1

chm 2 - Chm 2

chm 2 - Chm 2

Figure 1 - Figure 1

Figure 1 - Figure 1

This text provides a breakdown of a study's results by different subgroups such as sex, age, infarct location, presence of diabetes, prior myocardial infarction, type of fibrinolytic agent and time to treatment. The study evaluated outcomes including patient numbers, relative risk, and event rates for certain endpoints within a specified time frame. It further suggests the reduction in risk achieved with Enoxaparin compared to UFH (Unfractionated Heparin) and indicates which treatment option is deemed better based on the data.*

Figure 2 - Figure 2

Figure 2 - Figure 2

Figure A - Figure A

Figure A - Figure A

Figure B - Figure B

Figure B - Figure B

Figure C - Figure C

Figure C - Figure C

Figure D - Figure D

Figure D - Figure D

Figure E - Figure E

Figure E - Figure E

Figure A - IFU Fig A

Figure A - IFU Fig A

This text provides information about sharps disposal, including a container for one cotton ball or gauze, one alcohol wipe, and one small adhesive bandage. It also references a prefilled syringe.*

Figure B - IFU Fig B

Figure B - IFU Fig B

Figure C - IFU Fig C

Figure C - IFU Fig C

Figure D - IFU Fig D

Figure D - IFU Fig D

Figure E - IFU Fig E

Figure E - IFU Fig E

Figure F - IFU Fig F

Figure F - IFU Fig F

Figure G - IFU Fig G

Figure G - IFU Fig G

Figure H - IFU Fig H

Figure H - IFU Fig H

Figure I - IFU Fig I

Figure I - IFU Fig I

Figure J - IFU Fig J

Figure J - IFU Fig J

Figure K - IFU Fig K

Figure K - IFU Fig K

Figure L - IFU Fig L

Figure L - IFU Fig L

Figure M - IFU Fig M

Figure M - IFU Fig M

Figure N - IFU Fig N

Figure N - IFU Fig N

This product is a syringe with a needle cap. It is used for administering injections or drawing liquids. The needle cap is used to cover and protect the needle when not in use.*

parts - Parts

parts - Parts

This text provides instructions for a medical device with components like a plunger, rod, needle, needle cap, and protective sleeve. The text also includes a caution mentioning "Before Use" and a section about disposing the device "After Use".*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.